AbbVie Inc.·4

Feb 27, 5:00 PM ET

Siatis Perry C 4

Research Summary

AI-generated summary

Updated

AbbVie (ABBV) EVP Perry C. Siatis Exercises Options, Sells Shares

What Happened Perry C. Siatis, EVP, General Counsel and Secretary of AbbVie, exercised employee stock options for a total of 22,381 shares on Feb 25, 2026 and sold those 22,381 shares the same day in an open-market transaction. The exercises were in three tranches: 7,314 shares at $149.62 (exercise cost $1,094,321), 7,775 shares at $175.28 (exercise cost $1,362,802), and 7,292 shares at $192.86 (exercise cost $1,406,335) — aggregate exercise cost $3,863,458. The 22,381 shares were sold in the open market at $230.00 per share for total proceeds of $5,147,630 (filed on Feb 27, 2026). The filing also reports corresponding derivative dispositions tied to the option exercises. This pattern indicates a same-day exercise-and-sell (cashless exercise) rather than a new long-term purchase.

Key Details

  • Transaction date: 2026-02-25; Filing date: 2026-02-27 (timely filing).
  • Exercises (M): 7,314 @ $149.62; 7,775 @ $175.28; 7,292 @ $192.86 — total exercise cost $3,863,458.
  • Sale (S): 22,381 shares @ $230.00 — total proceeds $5,147,630.
  • Net cash difference (sale proceeds minus exercise cost) ≈ $1,284,172 (before taxes/fees).
  • Shares owned after transaction: not specified in the provided excerpt—see the full Form 4 for total beneficial ownership.
  • Footnotes: all options were granted under the AbbVie Amended & Restated 2013 Incentive Stock Program and are reportable as transactions exempt from Section 16 under Rule 16b-3; vesting schedules for the tranches are noted in the filing.

Context

  • The filings show an exercise of vested employee options followed by an immediate sale of the resulting shares — a common way for insiders to realize value and cover exercise costs/taxes. This is generally considered routine insider liquidity rather than a directional buy signal.
  • “M” denotes option exercise; the matching sale of 22,381 shares matches the total exercised shares, confirming the cashless-like pattern.
  • No 10b5-1 plan, gift, or late-filing indication was noted in the provided data; the report appears timely based on transaction and filing dates.